Our Advantages
Unique T cell gene screening and editing platform
-
Leading CGT Team
Academician + CEO
40+ employees，with over 70% in R&D, most of them are PhDs and masters
-
Our Pipelines
Scientific driven, discover FIC/BIC targets to reduce T-cell exhaustion
Pipeline includes multiple TIL and Treg products, with two products already in or about to enter clinical trials
-
Innovative Technology Platform
Cutting-edge TIL product rapid process platform
Novel gene-edited TIL GMP production platform
Product Pipeline
Dedicated to tackling unresolved challenges such as solid tumors and autoimmune diseases
-
Pipeline
-
Category
-
Indication
-
Mechanism
-
Early Discovery
-
POC
-
Pre-clinical
-
IIT
-
IND
-
-
Ben-102
Ben-201
Ben-202
Ben-203
-
TIL/ Engineered-TIL
-
Solid Tumor
-
Fast & Feeder Free Enhanced Process
Promote T-cell proliferation and reduce T-cell exhaustion
Promote T-cell function and reduce T-cell exhaustion
Enhance stemness of T-cell and improve anti-tumor activity
-
-
-
-
Ben-301
-
Engineered-Treg
-
Autoimmune Diseases
-
Inhibit T&B Cell proliferation and Ab production
-
-
Pipeline：Ben-301
Category：TIL/ Engineered-TIL
Indication：Solid Tumor
Early Discovery
POC
Pre-clinical
IIT
IND
Mechanism：Fast & Feeder Free Enhanced Process
Indication：Solid Tumor
Early Discovery
POC
Pre-clinical
IIT
IND
Mechanism：Promote T-cell proliferation and reduce T-cell exhaustion
Indication：Solid Tumor
Early Discovery
POC
Pre-clinical
IIT
IND
Mechanism：Promote T-cell function and reduce T-cell exhaustion
Indication：Solid Tumor
Early Discovery
POC
Pre-clinical
IIT
IND
Mechanism：Enhance stemness of T-cell and improve anti-tumor activity
Pipeline：Ben-203
Category：Engineered-Treg
Indication：Autoimmune Diseases
Early Discovery
POC
Pre-clinical
IIT
IND
Mechanism：Inhibit T&B Cell proliferation and Ab production
Technology Platforms
-
nu-TECH
Utilize engineering techniques to mitigate T cell exhaustion, augment stemness, and amplify functional T cells
The utilization of cutting-edge technology and gene editing techniques is employed to enhance the desiccation resistance and memory capacity of T cells, thereby decelerating their depletion rate. This approach aims to achieve rapid expansion of functional T cells and augment their cytotoxicity.
Learn More
nu-TECH
-
nu-GENE
Cutting-edge T-cell target screening and gene editing platform for unique immunotherapy with precise experimental cell manipulation.
Through T-cell engineering and the establishment of unique in vitro and in vivo models, our objective is to achieve precise and functional assessment of T-cell immunotherapy.
Learn More
nu-GENE
Join Us